Fenoldopam Inhibits Nuclear Translocation of Nuclear Factor Kappa B in a Rat Model of Surgical Ischemic Acute Renal Failure

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 20, Issue 2, 2006, Pages 179-186

  Aravindan, Natarajan ^a   Natarajan, Mohan ^b   Shaw, Andrew D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

acute renal failure; fenoldopam; inflammation; ischemia reperfusion injury; NF B; rat kidney

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; FENOLDOPAM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; SOMATOMEDIN C; URETHAN;

ACUTE KIDNEY FAILURE; ANESTHESIA; ANESTHESIOLOGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; ATTENUATION; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; GENE INDUCTION; GENE REPRESSION; GENE TRANSLOCATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; INFLAMMATION; KIDNEY ISCHEMIA; KIDNEY SLICE; MALE; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL ARTERY; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURGICAL INJURY; VALIDATION PROCESS;

ANIMALS; DISEASE MODELS, ANIMAL; DNA; FENOLDOPAM; FOLLOW-UP STUDIES; GENE EXPRESSION; INFUSIONS, INTRAVENOUS; INSULIN-LIKE GROWTH FACTOR I; ISCHEMIA; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE III; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; VASODILATOR AGENTS;

EID: 32644484494     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2005.03.028     Document Type: Article

References (42)

1. Brady H.R., Brenner B.M., Clarkson M.R., et al. Acute renal failure. In: Brenner B.M. (Ed). The Kidney. ed 6 (2000), Saunders, Philadelphia, PA 1201-1262
2. Thadhani R., Pascual M., and Bonventre J.V. Acute renal failure. N Engl J Med 334 (1996) 1448-1460
3. Ashworth S.L., and Molitoris B.A. Pathophysiology and functional significance of apical membrane disruption during ischemia. Curr Opin Nephrol Hypertens 8 (1999) 449-458
4. Cosentino F. Drugs for the prevention and treatment of acute renal failure. Cleve Clin J Med 62 (1995) 248-253
5. Dishart M.K., and Kellum J.A. An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure. Drugs 59 (2000) 79-91
6. Liu Z.X., Nickel C.H., and Cantley L.G. HGF promotes adhesion of ATP-depleted renal tubular epithelial cells in a MAPK-dependent manner. Am J Physiol Renal Physiol 281 (2001) F62-F70
7. Edelstein C.L., Alkhunaizi A.A., and Schrier R.W. The role of calcium in the pathogenesis of acute renal failure. Ren Fail 19 (1997) 199-207
8. Peng M., Huang L., Xie Z.J., et al. Oxidant-induced activations of nuclear factor-kappa B and activator protein-1 in cardiac myocytes. Cell Mol Biol Res 41 (1995) 189-197
9. Donnahoo K.K., Meldrum D.R., Shenkar R., et al. Early renal ischemia, with or without reperfusion, activates NFkappaB and increases TNF-alpha bioactivity in the kidney. J Urol 163 (2000) 1328-1332
10. Donnahoo K.K., Shames B.D., Harken A.H., et al. Review article. The role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 162 (1999) 196-203
11. Lenardo M.J., and Baltimore D. NF-kappa B. A pleiotropic mediator of inducible and tissue-specific gene control. Cell 58 (1989) 227-229
12. Smale S.T., and Baltimore D. The "initiator" as a transcription control element. Cell 57 (1989) 103-113
13. Tumlin J.A., Dunbar L.M., Oparil S., et al., Fenoldopam Study Group. Fenoldopam, a dopamine agonist, for hypertensive emergency. A multicenter randomized trial. Acad Emerg Med 7 (2000) 653-662
14. Ranucci M., Soro G., Barzaghi N., et al. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. Ann Thorac Surg 78 (2004) 1332-1337 ; discussion 78:1337-1338, 2004
15. Miller Q., Peyton B.D., Cohn E.J., et al. The effects of intraoperative fenoldopam on renal blood flow and tubular function following suprarenal aortic cross-clamping. Ann Vasc Surg 17 (2003) 656-662
16. Caimmi P.P., Pagani L., Micalizzi E., et al. Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 17 (2003) 491-494
17. Garwood S., Swamidoss C.P., Davis E.A., et al. A case series of low-dose fenoldopam in seventy cardiac surgical patients at increased risk of renal dysfunction. J Cardiothorac Vasc Anesth 17 (2003) 17-21
18. Halpenny M., Rushe C., Breen P., et al. The effects of fenoldopam on renal function in patients undergoing elective aortic surgery. Eur J Anaesthesiol 19 (2002) 32-39
19. Halpenny M., Lakshmi S., O'Donnell A., et al. Fenoldopam. Renal and splanchnic effects in patients undergoing coronary artery bypass grafting. Anaesthesia 56 (2001) 953-960
20. Gilbert T.B., Hasnain J.U., Flinn W.R., et al. Fenoldopam infusion associated with preserving renal function after aortic cross-clamping for aneurysm repair. J Cardiovasc Pharmacol Ther 6 (2001) 31-36
21. Mathur V.S., Swan S.K., Lambrecht L.J., et al. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 27 (1999) 1832-1837
22. 2 and urine output in a rat model of surgical acute renal insufficiency. Crit Care Med 31 (2003) A152
23. Sheinbaum R., Ignacio C., Safi H.J., et al. Contemporary strategies to preserve renal function during cardiac and vascular surgery. Rev Cardiovasc Med 4 suppl 1 (2003) S21-S28
24. National Research Council. Guide for the Care and Use of Laboratory Animals. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council (1996), National Academy Press, Washington, DC 1-118
25. Maas W., de Graaf I., Schoen E., et al. Assessment of some critical factors in the freezing technique for the cryopreservation of precision-cut rat liver slices. Cryobiology 40 (2000) 250-263
26. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
27. Tang Y., Lu A., Aronow B.J., et al. Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia. Eur J Neurosci 15 (2002) 1937-1952
28. Medina A., Fernandez-Fuente M., Carbajo-Perez E., et al. Insulin-like growth factor I administration in young rats with acute renal failure. Pediatr Nephrol 17 (2002) 1005-1012
29. Baker J.E. Oxidative stress and adaptation of the infant heart to hypoxia and ischemia. Antioxid Redox Signal 6 (2004) 423-429
30. Liu M.T., Huang H.M., Jeng K.C., et al. Induction of cytokine genes and IL-1alpha by chemical hypoxia in PC12 cells. Life Sci 67 (2000) 2147-2157
31. Gonzalez-Parra S., Rosato R.R., Chowen J.A., et al. Inverse correlation between insulin-like growth factor (IGF)-binding protein-5 and IGF-I and II during postnatal development of the anterior pituitary gland. Horm Res 57 (2002) 10-14
32. Bayraktutan U., Yang Z.K., and Shah A.M. Selective dysregulation of nitric oxide synthase type 3 in cardiac myocytes but not coronary microvascular endothelial cells of spontaneously hypertensive rat. Cardiovasc Res 38 (1998) 719-726
33. Hierholzer C., Kelly E., Tsukada K., et al. Hemorrhagic shock induces G-CSF expression in bronchial epithelium. Am J Physiol 273 (1997) L1058-L1064
34. Murai Y., Dobashi Y., Okada E., et al. Study on the role of G1 cyclins in Epstein-Barr virus-associated human lymphomas maintained in severe combined immune deficiency (SCID) mice. Int J Cancer 92 (2001) 232-239
35. Murray C., Markos F., Snow H.M., et al. Effects of fenoldopam on renal blood flow and its function in a canine model of rhabdomyolysis. Eur J Anaesthesiol 20 (2003) 711-718
36. Nichols T.C. NF-kappaB and reperfusion injury. Drug News Perspect 17 (2004) 99-104
37. Meldrum K.K., Hile K., Meldrum D.R., et al. Simulated ischemia induces renal tubular cell apoptosis through a nuclear factor-kappaB dependent mechanism. J Urol 168 (2002) 248-252
38. Gueler F., Rong S., Park J.K., et al. Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol 13 (2002) 2288-2298
39. Cao C.C., Ding X.Q., Ou Z.L., et al. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int 65 (2004) 834-845
40. Vos I.H., Govers R., Grone H.J., et al. NFkappaB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts. FASEB J 14 (2000) 815-822
41. Burne-Taney M.J., and Rabb H. The role of adhesion molecules and T cells in ischemic renal injury. Curr Opin Nephrol Hypertens 12 (2003) 85-90
42. Li C., Ha T., Kelley J., et al. Modulating Toll-like receptor mediated signaling by (1→3)-beta-d-glucan rapidly induces cardioprotection. Cardiovasc Res 61 (2004) 538-547